G. M. Hoffmann — Endo Lab

article 1996

[Long-term observations of the extent and reversibility of bone demineralization after leuprorelin acetate depot therapy].

Zentralblatt für Gynäkologie

Therapy of endometriosis with a GnRH-agonist (Leuprorelin) demonstrated a good therapeutical efficiency. As a side effect it had a significant negative impact on trabecular bone mass (non significant on cortical bone) as measured by DXA. Ri…

article 1996

[Results of long-term follow-up in treatment of endometriosis with the GnRH agonist leuprorelin acetate depot (Enantone-Gyn monthly depot)].

Zentralblatt für Gynäkologie

In a previous study 198 patients with histologically confirmed endometriosis underwent a "three-step" therapy, where surgical removal of endometriosis implants was followed by a 6 months treatment with 3.75 mg leuprorelinacetate depot as mo…

article 1990

[GnRH-agonists in the therapy of endometriosis].

Therapeutische Umschau. Revue therapeutique

Repeated application of GnRH agonists causes a reversible suppression of ovarian function. Suppression on estrogen release is the fundamental idea of this hormonal therapy of endometriosis. We treated twelve patients with histologically pro…